In this study we aim to correct mutations within COL7A1 that cause malfunction, reduction or complete absence of type VII collagen in the skin’s basement membrane zone (BMZ), leading dystrophic epidermolysis bullosa (DEB), a severe and rare skin blistering disease associated with high risk cancer as well increased mortality. Therefore, use 3’-RTMS6m repair molecule develop safe, non-viral, non-...

Recessive dystrophic epidermolysis bullosa (RDEB) is a blistering skin disease caused by mutations in COL7A1, the gene encoding type VII collagen (C7). RDEB characterized chronic wounds and high incidence of aggressive squamous cell carcinoma (SCC), leading cause death this patient population. High mobility group box 1 (HMGB1) serum biomarker severity patients that may have mechanistic role pro...